Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules
- PMID: 18836633
Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules
Abstract
State-of-the-art magnetic resonance (MR) imaging using tissue specific contrast media facilitates detection and characterization in most cases of hepatic nodules. According to the currently used nomenclature, in liver cirrhosis there are only two major types of hepatocellular nodular lesions: regenerative lesions and dysplastic or neoplastic lesions. The purpose of this clinical imaging review is to provide information on the properties of tissue-specific MR contrast agents and on their usefulness in the demonstration of the pathologic changes that take place at the level of the hepatobiliary and reticuloendothelial systems during the carcinogenesis in liver cirrhosis.
Similar articles
-
Hepatocellular nodules in liver cirrhosis: MR evaluation.Abdom Imaging. 2011 Jun;36(3):282-9. doi: 10.1007/s00261-011-9692-2. Abdom Imaging. 2011. PMID: 21399975 Review.
-
Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.Radiographics. 2002 Sep-Oct;22(5):1023-36; discussion 1037-9. doi: 10.1148/radiographics.22.5.g02se061023. Radiographics. 2002. PMID: 12235331 Review.
-
Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.Abdom Imaging. 2011 Jun;36(3):290-9. doi: 10.1007/s00261-011-9687-z. Abdom Imaging. 2011. PMID: 21267561 Review.
-
Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.Curr Probl Diagn Radiol. 2008 May-Jun;37(3):104-14. doi: 10.1067/j.cpradiol.2007.07.003. Curr Probl Diagn Radiol. 2008. PMID: 18436110 Review.
-
MR imaging of the liver. Cirrhosis and premalignant nodules.Magn Reson Imaging Clin N Am. 1997 May;5(2):331-46. Magn Reson Imaging Clin N Am. 1997. PMID: 9113678 Review.
Cited by
-
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.Hepat Med. 2010 Aug 17;2:111-24. doi: 10.2147/HMER.S9052. Hepat Med. 2010. PMID: 24367211 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical